the conundrum of antithrombotic therapy in atrial fibrillation patients undergoing tavi-europcr 2022
Published 2 years ago • 2.1K plays • Length 56:18Download video MP4
Download video MP3
Similar videos
-
54:59
double jeopardy: coronary disease in patients undergoing tavi - europcr 2022
-
56:23
challenges and opportunities in high-risk patients undergoing tavi - europcr 2021
-
50:01
anti-thrombotic therapy after tavi, dr. raul moreno
-
59:28
the role of coronary interventionalist in tavi - from referral to timing of pci - europcr 2022
-
1:01:43
learnings from an optimised tavi patient's journey - europcr 2022
-
5:45
hemodynamics and minimalist tavi - how does it fit? - europcr 2022
-
1:28:52
remaining unmet needs and strategies in tavi - pcr london valves 2022
-
46:19
procedural aspects of tavi patient long-term management
-
58:45
tavi: how to best manage concomitant procedures in structural heart therapies? europcr 2017
-
9:21
efficient tavi in the context of expanding indications - europcr 2021
-
7:40
5 year predictions for tavi as a therapy for aortic stenosis - europcr 2023
-
58:21
optimising immediate and long-term outcomes after tavi - pcr london valves 2022
-
56:53
how should heart teams adapt to recently-updated valvular heart disease guidelines? - webinar
-
9:48
duravr thv: a valve designed for life - europcr 2022
-
55:58
introducing navitor: a new tavi solution - europcr 2021
-
1:01:40
how can i mitigate complications for my tavi patients? - webinar
-
1:03:10
valve-in-valve: the journey starts with the first prosthesis - europcr 2022
-
40:32
tavi for ar - addressing an unmet need with the jenavalve trilogy heart valve system - europcr 2022
-
2:30
esc tv at #esccongress 2021 - envisage-tavi af